Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
Inside the Space Tech Firm Powering America’s Return to the Moon
Chris Edmunds, CFO of Redwire, discusses NASA missions, ISS innovation, space pharma, and the company’s rapid 2026 growth.
Why HealthCentral Is Betting Big on an App to Fix Medical Misinformation
HealthCentral CEO Justin Chase joins to discuss the drops app and its mission to combat medical misinformation and improve access to trusted health info.
Why Wall Street Is Betting Big on Cerebras
Cerebras CMO Julie Choi joins live from the NASDAQ to break down the company’s blockbuster IPO and AI ambitions.
Meet Amazon's $50,000 Robot - Inside Big Tech's Humanoid Takeover
Meet Sprout, the $50K robot Amazon just acquired. It walks, talks and dances. And it's just the beginning of Big Tech's push to put humanoids in your home.
Why Ouster’s New Color LiDAR Could Change Robotics Forever
Ouster CEO Angus Pacala explains how next-gen LiDAR and physical AI are transforming robotics, automation, and autonomy.
Could Oil Prices Spike Again This Summer?
Rob Thummel of Tortoise Capital breaks down oil prices, geopolitical risks, and what a volatile energy market could mean for investors and consumers this summer
